| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $163.07B | $154.00B | $144.55B | $125.98B | $111.11B | $74.64B | $60.12B | $48.38B |
| Cost of Revenue | $146.24B | $136.68B | $127.89B | $111.78B | $95.90B | $65.80B | $51.70B | $42.58B |
| Gross Profit | $16.83B | $17.32B | $16.66B | $14.20B | $15.22B | $8.84B | $8.42B | $5.80B |
| Gross Margin | 10.32% | 11.24% | 11.52% | 11.27% | 13.69% | 11.85% | 14.01% | 11.99% |
| Operating Expenses | $13.65B | $14.38B | $15.34B | $12.41B | $12.13B | $7.06B | $6.96B | $4.60B |
| Operating Income | $3.17B | $2.93B | $1.32B | $1.78B | $3.08B | $1.78B | $1.46B | $1.20B |
| Operating Margin | 1.95% | 1.90% | 0.91% | 1.42% | 2.77% | 2.39% | 2.43% | 2.48% |
| Net Income | $3.31B | $2.70B | $1.20B | $1.35B | $1.81B | $1.32B | $900.00M | $828.00M |
| Net Margin | 2.03% | 1.75% | 0.83% | 1.07% | 1.63% | 1.77% | 1.50% | 1.71% |
| EPS (Basic) | $6.33 | $4.97 | $2.09 | $2.31 | $3.17 | $3.19 | $2.31 | $2.40 |
| EBITDA | $6.20B | $5.62B | $4.06B | $3.81B | $4.76B | $2.84B | $2.21B | $1.75B |
| Stock Option Compensation Expense | $212.00M | $216.00M | $234.00M | $203.00M | $281.00M | $177.00M | $145.00M | $135.00M |
| Price To Earnings Ratio | 9.56 | 14.92 | 39.24 | 35.65 | 18.95 | 19.68 | 25.00 | 21.02 |
| Price To Sales Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Capitalization | $31.61B | $40.32B | $47.17B | $48.03B | $34.26B | $26.00B | $22.50B | $17.40B |
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Short Term Receivables | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventories | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Property, Plant & Equipment | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Investments and Advances | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Note Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Intangible Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Deferred Tax Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Assets | $82.44B | $84.64B | $76.87B | $78.38B | $68.72B | $40.99B | $30.90B | $21.86B |
| Short Term Debt Incl. Current Port. of LT Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Provision for Risks Charges | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Deferred Tax Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $55.94B | $58.69B | $52.63B | $51.35B | $42.76B | $28.30B | $19.88B | $14.98B |
| Non-Equity Reserves | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Preferred Stock - Carrying Value | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Common Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Shareholders Equity | $26.41B | $25.84B | $24.06B | $26.80B | $25.77B | $12.55B | $10.92B | $6.85B |
| Accumulated Minority Interest | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $26.41B | $25.84B | $24.06B | $26.80B | $25.77B | $12.55B | $10.92B | $6.85B |
| Total Liabilities & Stockholders Equity | $82.44B | $84.64B | $76.87B | $78.38B | $68.72B | $40.99B | $30.90B | $21.86B |
| Book Value Per Share | $50.81 | $47.77 | $42.14 | $46.36 | $45.49 | $30.70 | $28.25 | $19.93 |
| Tangible Book Value Per Share | $6.79 | $4.23 | $-2.58 | $-0.98 | $-1.89 | $9.11 | $4.53 | $2.11 |
| Full-Time Employees | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price to Book Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | 4.01% | 3.19% | 1.56% | 1.72% | 2.63% | 3.22% | 2.91% | 3.79% |
| Return on Equity | 12.51% | 10.46% | 5.00% | 5.03% | 7.02% | 10.53% | 8.24% | 12.09% |
| Return on Invested Capital | 5.07% | 4.56% | 1.66% | 2.48% | 4.20% | 4.62% | 5.02% | 6.82% |
| Quick Ratio | 1.11 | 1.11 | 1.06 | 1.11 | 1.08 | 1.57 | 1.00 | 0.93 |
| Current Ratio | 1.11 | 1.11 | 1.06 | 1.11 | 1.08 | 1.57 | 1.00 | 0.93 |
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $3.31B | $2.70B | $1.20B | $1.35B | $1.81B | $1.32B | $900.00M | $828.00M |
| Depreciation | $1.24B | $1.29B | $1.43B | $1.33B | $1.26B | $643.00M | $495.00M | $361.00M |
| Other Funds (Non Cash) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Funds from Operations | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Extraordinary Item | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Changes in Working Capital | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Taxes Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Operating Activities | $154.00M | $8.05B | $6.26B | $4.21B | $5.50B | $1.48B | $1.23B | $1.49B |
| Capital Expenditures | $644.00M | $799.00M | $1.00B | $910.00M | $869.00M | $730.00M | $675.00M | $422.00M |
| Net Assets From Acquisitions | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale of Fixed Assets and Businesses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Purchase or Sale of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Purchase of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale Or Maturity of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Uses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Sources | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Investing Activities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Dividends Paid | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Change in Capital Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Repurchase of Common Pref Stock | $3.12B | $1.63B | $3.10B | $297.00M | $626.00M | $75.00M | $71.00M | $65.00M |
| Sale of Common Pref Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Proceeds from Stock Options | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Issuance or Reduction of Debt, Net | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Change in Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Issuance of Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Reduction of Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Financing Active Other Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Financing Activities Uses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Financing Activities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Change in Cash | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | $-490.00M | $7.25B | $5.26B | $3.29B | $4.63B | $753.00M | $559.00M | $1.07B |
| Preferred Dividends (Cash Flow) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price to Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Company coverage
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
Why it moved over time
Centene Corporation (CNC) was named a Zacks Rank #1 (Strong Buy) growth stock on Aug. 13, 2026, a prominent ranking that can drive investor interest and higher trading activity.
Key fact: Zacks ranked Centene Corporation (CNC) as a Rank #1 (Strong Buy) growth stock on Aug 13, 2026.
zacks.com: Best Growth Stocks to Buy for August 13thCentene Corporation (CNC) is likely reacting to Diamond Hill's initiation of a position, signaling fresh institutional buying and a vote of confidence that can boost demand and valuation perception.
Key fact: Diamond Hill Small-Mid Cap Fund initiated a position in Centene in its Q2 2026 portfolio review (published Aug. 6, 2026).
seekingalpha.com: Diamond Hill Small-Mid Cap Fund Q2 2026 Portfolio ReviewCentene reported stronger-than-expected Q2 results and raised its 2026 EPS outlook after margin recovery and higher premium/service revenue, signaling improved profitability despite softer Medicaid membership.
Key fact: Q2 EPS $2.51 vs Zacks estimate $0.89; company raised its 2026 EPS outlook.
zacks.com: Centene Stock Q2 Earnings Call Highlights Margin Recovery